Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease (COPD): A Meta-Analysis of METREX and METREO Patient-Reported Outcomes, Response to Therapy and Lung Function
Main Authors: | , , , , , , , , , |
---|---|
格式: | Conference item |
出版: |
American Thoracic Society
2018
|